Smiles, teamwork, and real progress 💪 Great to see the INTERCEPTOR community together in Paris for the annual meeting — proud of what’s been achieved so far! #INTERCEPTOR #TeamScience

🔬 Want to level up your virology skills? ERINHA member is organizing a Course in Virology at Erasmus MC (23–27 Nov 2026), bringing together top European experts. 🧬 Emerging viruses, immune response, clinical insights & more 💰 €100 | Limited seats 👉 Don’t miss it! #InfectiousDiseases #ERINHA

📢 New publication in PLOS Biology ERINHA is proud to have coordinated this perspective on strengthening international biosafety and biosecurity practices. Read it here: journals.plos.org/plosbiology/...

Attending the "International Symposium on Tick Borne Pathogens and Disease ITPD 2026"? https://www.itpd-tickborne.com/2026/programme.php Come and meet Iva Trifonova from Iva Cristova's team, our partner and WP leader in #CCHFVACIM project https://www.cchfvacim.eu/

We are recruiting a European Project Manager (Junior profile) to join ERINHA’s Central Coordinating Unit in Paris. 📍 Paris (hybrid) 📝 Apply by 3 April 2026 📅 Start: May 2026 Full details and how to apply: erinha.eu/news/vacancy...

25–26 Feb 2026, Rome: the RICH Europe Symposium highlights best practices in RI collaboration, interoperability & data sharing across @horizoneu.bsky.social Diana Stepanyan will present ISIDORe: how integrated RI services accelerate research on epidemic-prone pathogens. 🔗 shorturl.at/OrZJU

🚀 #CCHFVACIM is advancing an mRNA vaccine against CCHF toward Phase II trials — building on CCHFVaccine results. Progress relies on sustained BSL-3/4 access and strong European collaboration. 🔗 Read more: https://cchfvacim.pulse.ly/w0zkvexwgw

Science alone won’t stop Lassa fever 3 vaccine candidates are in development; one could be licensed within a decade. West African countries must prepare now: define priority groups, strengthen regulation, secure financing, plan delivery, and build trust https://project-syndicate.pulse.ly/xq1qpeyqci

🔬 From neglected disease to vaccine candidates. #CCHFVaccine advanced CCHF research w/ new models, secure sample pipelines & high-containment access 🧬 DNA & mRNA vaccines now lead the way — EU collaboration turning preparedness into solutions. https://europa.pulse.ly/n46d36bhj3 @ec.europa.eu

Mpox continues to circulate globally. 2025: 52,845 confirmed cases / 98 countries. New outbreak in Madagascar (Dec 2025), clade Ib, community transmission ongoing. Research infrastructures matter. #Mpox #ERINHA https://who.pulse.ly/b4qtsarahe

🦠 A little-known virus. A very real risk for Europe Crimean-Congo Haemorrhagic Fever (CCHF) is a deadly tick-borne disease (up to 40% fatality) with no licensed vaccine 🔗 Read on CORDIS:https://cordis.europa.eu/article/id/463154-preventive-action-against-deadly-tick-borne-disease #CCHFVACIM

🌍 Six years after COVID-19: are we better prepared for the next pandemic? https://who.pulse.ly/gfqruvz3lm ✅ Yes, because major progress has been made ⚠️ No, because these gains remain fragile and uneven #PandemicPreparedness #WHO #ERINHA #OneHealth #Solidarity #ResearchInfrastructures

🔍 Understanding emerging health risks through scientific expertise As new cases of Nipah virus have been reported in India, The Conversation has published an in-depth, well-contextualised analysis by Allen Cheng, Professor of Infectious Diseases. https://theconversation.pulse.ly/rska4mshba

WHO regrets the US notification of withdrawal, warning it weakens global health security. The organization defends its COVID-19 response, rejects claims of politicization, and reaffirms its impartial, evidence-based mandate:https://who.pulse.ly/eq04kv08zn

Intranasal, broad-spectrum, structurally validated: a new macrocyclic peptide shows strong protection against SARS-CoV-2 Omicron variants. 📄 https://www.nature.com/articles/s41467-026-68462-9

🔬 New in Nature Communications: evidence of silent #mpox exposure in healthy adults in Nigeria. 🧬 Combining serology + genomics, the study shows how residual smallpox immunity shapes transmission — and why integrated surveillance matters. 📄 https://doi.org/10.1038/s41467-026-68335-1

Ethiopia declares end of first-ever Marburg virus disease outbreak https://www.afro.who.int/countries/ethiopia/news/ethiopia-declares-end-first-ever-marburg-virus-disease-outbreak

#Marburg in Tanzania (outbreaks 2023 & 2025): genome sequencing shows the strains were near-identical (>99.71% identity). Likely local spillover + limited human-to-human spread → need stronger eco/behavioral studies + surveillance in the Great Lakes zone. https://cdc.pulse.ly/otayrzokqs

Rwanda’s #Marburg response cut fatality rates to ~23% through rapid surveillance, genomics & coordinated action. A clear case for sustained investment in preparedness and research infrastructures. Nature Medicine: https://www.nature.com/articles/s41591-025-04163-y

#Nipah virus remains a high-risk pandemic threat with up to 70% fatality and no licensed vaccine. A new Nature Health Comment highlights urgent needs for better diagnostics, standardized assays, and vaccine-ready models to strengthen global outbreak preparedness. https://nature.pulse.ly/7dktxy8mw4

The EU has allocated €1.2 million in emergency aid to support the response to the Marburg outbreak in southern Ethiopia, strengthening surveillance, patient care, contact tracing and community engagement through WHO, International Medical Corps and the Red Cross. https://europa.pulse.ly/n3mybebsgd

🧪 As a partner in #ISIDORe, #ERINHA contributes its expertise on high-risk pathogens and preparedness, supporting Europe’s capacity to respond to emerging infectious diseases. 👉 Read on CORDIS: https://shorturl.at/k1SyC #ResearchInfrastructures #InfectiousDiseases #EUProjects

Emerging infectious diseases New in Nature: the oral antiviral 4′-fluorouridine protected non-human primates from lethal Lassa fever when administered at an advanced stage of infection. Read more: https://www.nature.com/articles/s41586-025-09906-y #HighConsequencePathogens #AntiviralResearch

🦇 Hendra virus detected in a bat in Australia’s Northern Territory (first confirmed NT detection; test 11 Dec 2025). Authorities say risk remains unchanged, but surveillance & biosecurity matter to reduce spillover risk. https://daf.nt.gov.au/news/2025/first-nt-detection-of-hendra-virus-in-a-bat

🔬 In Bangladesh, 5 severe “Nipah-like” cases linked to raw date palm sap tested NiV-negative. Sequencing identified Pteropine orthoreovirus (PRV), highlighting the need for broad surveillance & differential diagnosis in spillover settings. https://wwwnc.cdc.gov/eid/article/31/12/25-0797_article#;

One Health Trial Design could speed up #Lassa vaccine trials by combining ecological surveillance + viral genomics + socio-behavioral monitoring → smarter site selection + better case accrual + stronger real-world effectiveness estimates. https://www.nature.com/articles/s41591-025-04018-6

🧬 Lessons from the 2016 Ebola outbreak helped accelerate the first Lassa fever vaccine, now in Phase 1 human trials (Oxford + CEPI). The ChAdOx1 platform (used for COVID-19) will next be tested in Ghana, with plans for later trials in Nigeria. Read more: https://shorturl.at/b4M7w

🔬 New study in npj Viruses identifies cross-neutralizing antibodies that protect against both Marburg and Ravn viruses, two deadly filoviruses with no approved treatments. Lead candidates showed 100% protection in animal models. 👉 https://www.nature.com/articles/s44298-025-00168-z

⚠️ Nigeria: Lassa fever CFR reaches 18.2% (Week 50, 2025): 1,097 confirmed cases, 201 deaths across 21 states. No approved Lassa fever vaccine yet—highlighting the need for stronger preparedness and research. https://shorturl.at/yOR5d

🧬 Preparedness for high-risk pathogens: mRNA vaccines advance against Nipah virus.mRNA-LNP candidates targeting NiV F and G proteins provide robust immunity and full protection in hamsters — underlining the value of high-containment research. https://www.nature.com/articles/s41541-025-01336-1

🦠🌍 Zoonotic spillovers are rising. Deforestation, urbanization, intensive farming & climate change increase human–wildlife contact and outbreak risk. #OneHealth Read more: https://shorturl.at/mBNFV!/

🦠 H5N1: a warning worth taking seriously Finland became the first country to vaccinate high-risk groups against #H5N1 after a major outbreak in fur farms. Human cases are still rare, but the virus is spreading widely in animals and could mutate https://www.nature.com/articles/d41586-025-03612-5

🔬 New work in PLOS Pathogens shows how human gut #organoids can advance research on #Ebola and #Marburg virus infections in human-relevant systems: https://shorturl.at/V2GcS 🧩 How advanced in vitro models and high-containment infrastructures support preparedness in infectious disease research.

🚨 Big step for epidemic preparedness: Oxford just vaccinated the first volunteer in a first-in-human trial of the ChAdOx1 #Lassa fever vaccine. No licensed vaccine exists yet, ViTaL01 will assess safety + immune response. Read more: https://openaccessgovernment.pulse.ly/hxnmbzomou

UKHSA has found a new recombinant #mpox variant in England, mixing clade Ib + clade IIb — proof mpox is still evolving. Vaccination remains key for eligible risk groups. https://www.theguardian.com/world/2025/dec/08/england-health-officials-identify-newly-evolved-strain-of-mpox

France has confirmed 2 imported #MERS-CoV cases in travellers returning from a shared trip to the Arabian Peninsula. Patients are stable, hospitalized as a precaution. No secondary transmission detected so far. Contact tracing, testing & isolation measures are in place. https://urlr.me/YvhwdH

#Marburg update – Ethiopia (Dec 7, 2025) Cumulative total: 13 confirmed / 8 deaths (62% CFR) / 4 recovered / 1 active case, from 1,428 tests Response boosted with donated monoclonal antibody + intensive contact tracing. https://outbreaknewstoday.substack.com/p/marburg-monoclonal-antibody-donated

Ethiopia reports 3 deaths from #Marburg virus in its first confirmed outbreak. Marburg spreads through direct contact with bodily fluids and has a high fatality rate. Read more: https://www.aljazeera.com/news/2025/11/17/ethiopia-confirms-three-marburg-deaths-as-outbreak-sparks-regional-alarm

Great news from the #CCHFVACIM project! Colleagues just published a new rapid pseudotyped neutralisation assay for high-risk bunyaviruses, including CCHFV. Fast, adaptable, safe — and a major boost for vaccine development & Disease X preparedness. https://www.nature.com/articles/s41541-025-01278-8

New standard for BSL-4 research: MIHCLE Transparency, accountability & safety in high-containment science. #MIHCLE #ERINHA 👉 Read the Nature Comment : www.nature.com/articles/s41... #biosafety #biosecurity #MIHCLE #researchstandards #ERINHA #BSL4

A new milestone for outbreak readiness: 100,000 investigational #Nipah vaccine doses to be produced by CEPI, Oxford & Serum Institute. Built on the ChAdOx platform that helped fight COVID19. #GlobalHealth #Vaccines Read more: https://cepi.net/establishing-worlds-largest-nipah-virus-vaccine-reserve

🧬 A breakthrough for safer virus research By delivering purified nucleocapsids directly into cells—bypassing receptor-mediated infection—they open the door to non-infectious, biosafe approaches for studying and handling dangerous viruses. More: https://www.nature.com/articles/s41598-025-22282-x

EMA workshop: Non-clinical data for regulatory decision-making on the efficacy of medical countermeasures | European Medicines Agency (EMA) https://www.ema.europa.eu/en/events/ema-workshop-non-clinical-data-regulatory-decision-making-efficacy-medical-countermeasures

Read our correspondence in #Nature: Give the public a say in virology safeguards: https://rdcu.be/eOcx4

A wave of ancient plagues 5000 years ago changed everything — our DNA, immunity & societies. Read the beautifully illustrated story in New Scientist:https://www.newscientist.com/article/2500060-how-a-surge-in-ancient-plagues-5000-years-ago-shaped-humanity/ #AncientDNA #HumanEvolution #OneHealth

As Europe warms, #Hyalomma ticks carrying #CCHFV expand northward. https://parasitesandvectors.biomedcentral.com/articles/10.1186/s13071-025-07104-3 The #CCHFVACIM project unites partners across Europe to boost vaccine development & preparedness. #OneHealth #ERINHA

Nigeria faces another #Lassa fever surge — 18.6% fatality rate. Preparedness, not panic, must define the response. Read more: https://www.nationalaccordnewspaper.com/how-prepared-is-nigeria-for-another-lassa-fever-season/

🧪 Scientific Watch Rapid detection of high-consequence #infections in febrile travellers. ➡️ Results in under 1 hour, 85.7% sensitivity, 96% specificity. Fast diagnostics = faster decisions, less unnecessary isolation. 📌 Ref: https://sciencedirect.pulse.ly/qp3z7oa1ik

🧬 New Lancet Infectious Diseases study: children face >2x higher risk of Long COVID after reinfection. Even mild reinfections matter — prevention & monitoring remain key. At ERINHA, we support research that strengthens global preparedness. 🌍 https://thelancet.pulse.ly/ys4eabkfp0

🦠 The Republic of Congo is reinforcing Ebola preparedness with @WHO support — training staff, updating plans & strengthening surveillance. At #ERINHA, we share this commitment to global health security through biosafety research & collaboration. Preparedness must be global. 🌍 #Ebola #OneHealth